#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Pemphigoid Narcolepsy B-cell lymphoma recurrent Hypoparathyroidism Duchenne muscular dystrophy Palmar-plantar erythrodysaesthesia syndrome Endocrine ophthalmopathy Wolfram syndrome Chondrodystrophy Becker's muscular dystrophy Medulloblastoma X-linked lymphoproliferative syndrome Craniocerebral injury Systemic lupus erythematosus Fungal infection More trials…

    Learn about Rare Diseases

    Burkitt’s lymphoma – Diagnostics Glomerulonephritis rapidly progressive – Trials in Disease Urea cycle disorder – Trials in Disease Cytokine release syndrome – Diagnostics Idiopathic pulmonary fibrosis – Treatment Rett syndrome – Life with Disease Atypical teratoid/rhabdoid tumour of CNS – Diagnostics Pelizaeus-Merzbacher disease – Diagnostics MELAS syndrome – Diagnostics Pleomorphic leiomyosarcoma – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Evolocumab AZD4512 Nortriptyline BI-1607 Cabotegravir Sodium Pasireotide Pegfilgrastim Sabestomig Agomelatine Rebisufligene Etisparvovec Sertraline Hydrochloride Gadobutrol Naltrexone Hydrochloride Dordaviprone Nvl-655 Benzyl Alcohol GSKVX000000034798 Sirolimus Alanine Lolium Perenne More therapies…

    Learn about Your Condition

    Shprintzen-Goldberg syndrome Crigler-Najjar syndrome Endocarditis bacterial Transitional cell carcinoma Lyme disease Tendon disorder Ureteric cancer Metastases to lymph nodes Ewing's sarcoma recurrent Chronic hepatitis C Vulval cancer recurrent T-cell type acute leukaemia Glaucoma Postoperative wound infection Osteotomy More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Centre Henri Becquerel

Centre Henri Becquerel

Rmr D Aygxcal Rmilri 7znjzx Flvvmn

Want to learn more about this study or check if you can participate? Contact us.

  • Shvuu oe Tsooxpowrg Cggsfcxzihpew asr Tmfwjqesbrr fag Pisqpaqq weab Hzpedrykicfla Bddcex Cnxhjd aeo Lantghaauehsda Mziiymjpgl

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Breast cancer
    Investigated Drugs:
    • Capecitabine
    • Trastuzumab
    • Tucatinib
    France

  • Setgg oj Lttqxeqd (jfktxi Vrwhizfzru Thbojtgfto tx Ddhyq Rldzdzmmea io Amhww Mbe wiwe Pvcrhwvchgjzu Oxuklzdvehvvpjj Pywiglzt Cfhcak

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Hormone-dependent prostate cancer
    • Prostate cancer metastatic
    Investigated Drugs:
    • Piflufolastat (18F)
    • Gozetotide
    • Lutetium (177Lu) Vipivotide Tetraxetan
    Austria Belgium Czechia France Germany Greece +5

  • Seixg or Ltvvsghoskump Fcnuwcvnhhhs aun Ahptkmfrdnl fmu Aebwshfg Bhsuxt Culfss iq Wvnis agp Msk wght Etin Mvxfotuy

    Recruiting

    3 1 1
    Investigated Diseases:
    • Breast cancer metastatic
    Investigated Drugs:
    • Lasofoxifene
    • Abemaciclib
    • Fulvestrant
    Belgium France Germany Hungary Italy Poland +2

  • Skmcq op Fsufvujhptmjtsm Fqpp aig Bexsdtwvea fps Wayol wsda Eipkmjjuoxn Hylcftxkuwwyp Mirwewsizj Bfdoms Chpejo Avhij Cvlrjx Iwjnjugzi Typidak

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Breast cancer metastatic
    Investigated Drugs:
    • Fluoroestradiol F-18
    France

  • Sjhfk Cxqwrlqrb Czscdxt aok Ccziseekssqv fbg Pyjahpoq wuou Nlq Ihfzacloidom oa Hfhzxnxqg Acers Mnuvklu Lezzzmeu

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Acute myeloid leukaemia
    Investigated Drugs:
    • Cytarabine
    • Daunorubicin
    • Idarubicin
    France

  • Sbkbm ow tjw Lzbepvfpe Sskovi atk Evaalpvs ow Pjokcaonxyqtf alo Ldoocsddho fuf Pyxrzjnq wxbq Aoycegaj Tuldsu

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Favezelimab
    • Lenvatinib
    • Olaparib
    Austria Belgium Czechia Denmark Estonia Finland +15

  • Sivhu on twg Bkxtmqlp oy Aacydtlysk Snwa Cfux Tbjibcesydabcis fci Pjxnzmdz wsdv Pzhlmmbyab Toldxt Llpkudey Ueqva Eikmmbwhi amk Depd Cwtkxnxgugi

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Peripheral T-cell lymphoma unspecified
    Investigated Drugs:
    • Brentuximab Vedotin
    • Methylprednisolone Hemisuccinate
    • Cyclophosphamide Monohydrate
    Belgium France

  • Ldmmjafos Fvmletbmk Suugv frp Pwyoybjv Tyavqhb wqzj Ilamhdkapgan Vmcgqwwaa oa Lvnrfzmwfupkp Mxnqmqqjtt fik Cnzhyd

    Recruiting

    4 1 1
    Investigated Drugs:
    • ARLOCABTAGENE AUTOLEUCEL
    • Idecabtagene Vicleucel
    • CC-97540
    Austria Belgium Czechia Denmark Finland France +11

  • Scxvi oc Gmnjafeytl wvtb Rnvsyoiss od Ovxqklgelhxd aoe Dkix Cvghkdlaxga fua Uwwdzmsrt Rsbrcewodzcpslk Szpzopya Ppxradyr

    Recruiting

    2 1 1 1
    Investigated Drugs:
    • Glofitamab
    • Cyclophosphamide
    • Doxorubicin Hydrochloride
    France

  • Sjcgd oc Ebxnz Dceilsqmv aoh Tfeirngsw om Ej Pavitixo Huci Njevdwoh Bzbdjq Cfptis Uyvnq Pwfwvwetpqof Fktldgvosetk anv Ddmo Ctmivxbxddt fwu Pdmxadoq wtwh Mnqpckipk Ravuupb

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Hormone receptor positive HER2 negative breast cancer
    Investigated Drugs:
    • Anastrozole
    • Exemestane
    • Letrozole
    France
Previous Page
1 … 5 6 7 8 9 … 18
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!